Senior investor and board member with experience in venture capital, growth equity, and consumer tech. Alison Gould has led investments in early-stage software and healthcare startups, focusing on go-to-market scaling and founder support. Known for operating background in product and commercial roles, she combines portfolio company board-level stewardship with deal sourcing and due diligence. Often cited for emphasis on unit economics, customer retention, and pragmatic growth strategies.
Senior investor and board member with experience in venture capital, growth equity, and consumer tech. Alison Gould has led investments in early-stage software and healthcare startups, focusing on go-to-market scaling and founder support. Known for operating background in product and commercial roles, she combines portfolio company board-level stewardship with deal sourcing and due diligence. Often cited for emphasis on unit economics, customer retention, and pragmatic growth strategies.
Combines a founder‑centric, growth-stage playbook with early-stage venture discipline, prioritizing capital-efficient SaaS, consumer tech and healthcare businesses with demonstrable unit economics. Emphasizes repeatable go‑to‑market motion, customer retention and payback metrics when underwriting opportunities, and prefers active board stewardship and founder partnership to de-risk scaling execution. Allocates follow‑on capital selectively to accelerate revenue expansion while protecting margin profile; time horizon is multi-year growth realization with tight risk controls around churn, CAC payback and capital productivity.
Combines a founder‑centric, growth-stage playbook with early-stage venture discipline, prioritizing capital-efficient SaaS, consumer tech and healthcare businesses with demonstrable unit economics. Emphasizes repeatable go‑to‑market motion, customer retention and payback metrics when underwriting opportunities, and prefers active board stewardship and founder partnership to de-risk scaling execution. Allocates follow‑on capital selectively to accelerate revenue expansion while protecting margin profile; time horizon is multi-year growth realization with tight risk controls around churn, CAC payback and capital productivity.
| Trades 312 | Longs Won 210/312 67% | Profit Factor 15.07 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $736,745.61 |
| Average Win $176,291.16 | Best Trade (Jul 14) $10.86M | Sharpe Ratio -11.65 |
| Average Loss -$24,077.27 | Worst Trade (Jul 14) -$318,517.41 | Z-Score 6.47 (100%) |
| Commissions $0 | Avg. Trade Length 10m 1w 4d | Expectancy $110,786.1 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.21% |
| Consecutive Losing Trades | 5,988 | 5,389 | 4,790 | 4,192 | 3,593 | 2,994 | 2,395 | 1,796 | 1,198 | 599 |